CD274 and non-small cell lung carcinoma: The aim of this study was to conduct a network meta-analysis (NMA) to evaluate the efficacy of the available PD-(L)1-containing immunotherapy strategies in monotherapy for the first-line treatment of patients with high PD-L1 expression (≥50%) and locally advanced or metastatic NSCLC.